Data centers are expanding fast, driving rising energy and water use. Sustainable design will determine whether this growth ...

At week 12, treatment with MZE829 resulted in a 35.6% mean uACR reduction in broad AMKD patients, 50% of the patients achieved a greater than ...

Disappointed investors punished Wave Life Sciences (NASDAQ: WVE), causing its shares to lose roughly half their value on Thursday after the RNA-based drug developer reported mixed early-stage interim ...

GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk In a phase 2 trial in Chinese ...

The Computer Weekly Security Think Tank considers the intersection of AI and IAM. In this article, learn how AI-driven IAM ...

PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat ...

Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...

Kardigan(TM), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, today announced ...

Besting Vertex Pharmaceuticals’ kidney disease asset wasn’t enough to impress Wall Street, which appears to be “getting hung ...

Researchers say there may be a peculiar "cavity" of reduced cosmic radiation that could provide Moon astronauts with shelter.

HLDI analysis of Mazda vehicles adds new data to the frequency-down, severity-up dynamic collision repairers are experiencing ...

U.S District Judge Mary McElroy said the agency's “slapdash imposition of political whims” was aimed only at accomplishing ...